About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Olmesartan Medoxomil Versus Losartan in Elderly and Very Elderly

Olmesartan Medoxomil Versus Losartan in Elderly and Very Elderly

NCT00751751·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

Age

65–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Age 65 years or older
Mean sitting diastolic BP = 100-114 mmHg and mean sitting systolic BP \>=150 mm HG

You may not be if

Secondary hypertension
Malignant hypertension
Severe heart failure (NYHA III-IV)
History or evidence of renal disease
Recent history of myocardial infarction
Hypersensitivity to study drugs
History of drug or alcohol abuse

The record

StatusCompleted

PhasePhase 3

Taking part441

StartedJun 2003

UpdatedSep 12, 2008

Conditions

Essential Hypertension

Where1

Darmstadt, Germany